Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.
What kinds of humoral responses are seen in patients with chronic pulmonary diseases during the 6 months after receipt of 2 doses of BNT162b2 mRNA COVID-19 vaccine?
How do individuals with undiagnosed asthma and COPD manifest these conditions over time, and how do these undiagnosed conditions affect quality of life?
Researchers assessed the occurrence and associated outcomes of frequent productive cough among patients with chronic obstructive lung disease and asthma.
In COPD, how does using single-inhaler triple therapy instead of multiple-inhaler triple therapy affect health care costs, mortality, and treatment adherence?
How does pulmonary rehabilitation of patients after COPD-related hospitalizations affect the overall cost of care and quality-adjusted life expectancy?